David Joyner Takes Helm at CVS Amid Aetna Challenge MD Bureau24 Oct 2024 9:45 AM ISTNew York: As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure recently, Wall Street analysts and some...
Zydus Secures WHO Approval for Typhoid Vaccine ZyVac TCV, Eligible for UN Procurement MD Bureau23 Oct 2024 6:46 PM ISTZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad.
Masina Hospital appoints Dr Akash Rajpal as Chief Operating Officer MD Bureau23 Oct 2024 4:37 PM ISTMumbai: Masina Hospital recently announced the appointment of Dr Akash Rajpal as its new Chief Operating Officer (COO).Bringing over 25 years of...
Camurus faces USFDA rejection on Acromegaly drug CAM2029 MD Bureau23 Oct 2024 4:21 PM ISTThe FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with acromegaly.
Novo Nordisk's oral Semaglutide cuts cardiovascular risks by 14 percent, study finds MD Bureau23 Oct 2024 3:29 PM ISTNovo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year.
NHS to Block Eli Lilly's Alzheimer's Drug Donanemab Over Cost Concerns: Report MD Bureau23 Oct 2024 2:43 PM ISTThe National Institute for Health and Care Excellence (NICE), which decides what drugs are available on the NHS, will rule that it is too expensive
Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59 MD Bureau23 Oct 2024 2:37 PM ISTThe approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
Alembic Pharma gets USFDA nod to Diltiazem Hydrochloride ER Capsules to treat hypertension MD Bureau22 Oct 2024 2:20 PM ISTMumbai: Drug maker Alembic Pharmaceuticals Ltd has recently announced that it has received final approval from the United States Food and Drug...
Sanofi's Opella sale faces political backlash amid fears of drug shortages MD Bureau22 Oct 2024 10:15 AM ISTParis: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund...
Sanofi, CD&R in exclusive talks over sale of USD17 billion Opella MD Bureau22 Oct 2024 10:00 AM ISTSanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024
India's Bioeconomy surges to USD 150 billion, but innovation gaps remain, says BIRAC MD MD Bureau22 Oct 2024 9:30 AM ISTBIRAC MD highlighted India's significant contributions to global healthcare, with 40 percent of the world's generic drugs being supplied by Indian...
